Bank of New York Mellon Corp lowered its holdings in Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 9.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 558,664 shares of the health services provider’s stock after selling 60,900 shares during the period. Bank of New York Mellon Corp owned about 0.32% of Teladoc Health worth $5,078,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Versant Capital Management Inc boosted its holdings in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares in the last quarter. KBC Group NV lifted its position in shares of Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after acquiring an additional 3,714 shares during the last quarter. Westside Investment Management Inc. boosted its stake in shares of Teladoc Health by 43.8% during the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after acquiring an additional 2,800 shares in the last quarter. GSA Capital Partners LLP acquired a new position in shares of Teladoc Health in the 3rd quarter worth $92,000. Finally, Summit Trail Advisors LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth $92,000. 76.82% of the stock is currently owned by institutional investors.
Teladoc Health Stock Up 2.8 %
Shares of Teladoc Health stock opened at $8.86 on Tuesday. The firm has a market cap of $1.54 billion, a price-to-earnings ratio of -1.54 and a beta of 1.27. The stock has a 50-day simple moving average of $10.54 and a 200-day simple moving average of $9.73. Teladoc Health, Inc. has a 52-week low of $6.76 and a 52-week high of $15.68. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.
Wall Street Analysts Forecast Growth
A number of research firms recently weighed in on TDOC. Piper Sandler decreased their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Oppenheimer dropped their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Royal Bank of Canada lifted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Bank of America boosted their target price on shares of Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and an average price target of $11.26.
View Our Latest Stock Report on TDOC
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
- Five stocks we like better than Teladoc Health
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Can TikTok Stock Picks Really Make You Rich?
- Conference Calls and Individual Investors
- The “Quality” Rotation: Back to Basics Investing
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.